Literature DB >> 22503310

Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes.

Anderson Mon1, Timothy C Durazzo, Dieter J Meyerhoff.   

Abstract

BACKGROUND: Little is known about the effects of alcohol dependence on cortical concentrations of glutamate (Glu) or gamma aminobutyric acid (GABA). We used proton magnetic resonance spectroscopy (MRS) to study cross-sectionally and longitudinally the concentrations of these in alcohol dependent individuals (ALC) during early abstinence from alcohol.
METHODS: Twenty ALC were studied at about one week of abstinence from alcohol (baseline) and 36 ALC at five weeks of abstinence and compared to 16 light/non-drinking controls (LD). Eleven ALC were studied twice during abstinence. Participants underwent clinical interviewing, blood work, neuropsychological testing, structural imaging and single-volume proton MRS at 4Tesla. Absolute concentrations of Glu, GABA and those of other (1)H MRS-detectable metabolites were measured in the anterior cingulate (ACC), parieto-occipital cortex (POC) and dorso-lateral prefrontal cortex (DLPFC). Relationships of metabolite levels to drinking severity and neurocognition were also assessed.
RESULTS: ALC at baseline had lower concentrations of Glu, N-acetylaspartate (NAA), choline- (Cho) and creatine-containing metabolites (Cr) than LD in the ACC, but had normal GABA and myo-inositol (mI) levels. At five weeks of abstinence, metabolite concentrations were not significantly different between groups. Between one and five weeks of abstinence, Glu, NAA and Cho levels in the ACC increased significantly. Higher cortical mI concentrations in ALC related to worse neurocognitive outcome.
CONCLUSION: These MRS data suggest compromised and regionally specific bioenergetics/metabolism in one-week-abstinent ALC that largely normalizes over four weeks of sustained abstinence. The correlation between mI levels and neurocognition affirms the functional relevance of this putative astrocyte marker. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503310      PMCID: PMC3419314          DOI: 10.1016/j.drugalcdep.2012.03.012

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  57 in total

Review 1.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Dorsal anterior cingulate cortex: a role in reward-based decision making.

Authors:  George Bush; Brent A Vogt; Jennifer Holmes; Anders M Dale; Douglas Greve; Michael A Jenike; Bruce R Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Manifestations of early brain recovery associated with abstinence from alcoholism.

Authors:  Andreas J Bartsch; György Homola; Armin Biller; Stephen M Smith; Heinz-Gerd Weijers; Gerhard A Wiesbeck; Mark Jenkinson; Nicola De Stefano; László Solymosi; Martin Bendszus
Journal:  Brain       Date:  2007-01       Impact factor: 13.501

4.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

Authors:  J T Sullivan; K Sykora; J Schneiderman; C A Naranjo; E M Sellers
Journal:  Br J Addict       Date:  1989-11

5.  Monitoring the effects of chronic alcohol consumption and abstinence on brain metabolism: a longitudinal proton magnetic resonance spectroscopy study.

Authors:  Gabriele Ende; Helga Welzel; Sigi Walter; Wolfgang Weber-Fahr; Alexander Diehl; Derik Hermann; Andreas Heinz; Karl Mann
Journal:  Biol Psychiatry       Date:  2005-08-08       Impact factor: 13.382

6.  Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.

Authors:  B C Schweinsburg; M J Taylor; O M Alhassoon; J S Videen; G G Brown; T L Patterson; F Berger; I Grant
Journal:  Alcohol Clin Exp Res       Date:  2001-06       Impact factor: 3.455

7.  Reliability of alcohol use indices. The Lifetime Drinking History and the MAST.

Authors:  H A Skinner; W J Sheu
Journal:  J Stud Alcohol       Date:  1982-11

8.  Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics.

Authors:  D Seitz; U Widmann; U Seeger; T Nägele; U Klose; K Mann; W Grodd
Journal:  Alcohol Clin Exp Res       Date:  1999-01       Impact factor: 3.455

Review 9.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

10.  Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Deborah S Hasin; Frederick S Stinson; Elizabeth Ogburn; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2007-07
View more
  60 in total

Review 1.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

2.  Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers.

Authors:  James J Prisciandaro; Joseph P Schacht; Andrew P Prescot; Perry F Renshaw; Truman R Brown; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2019-01-04       Impact factor: 3.455

Review 3.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

4.  Recreational alcohol use induces changes in the concentrations of choline-containing compounds and total creatine in the brain: a (1)H MRS study of healthy subjects.

Authors:  Nuran Tunc-Skarka; Wolfgang Weber-Fahr; Gabriele Ende
Journal:  MAGMA       Date:  2015-05-16       Impact factor: 2.310

5.  Chronic Cigarette Smoking in Healthy Middle-Aged Individuals Is Associated With Decreased Regional Brain N-acetylaspartate and Glutamate Levels.

Authors:  Timothy C Durazzo; Dieter J Meyerhoff; Anderson Mon; Christoph Abé; Stefan Gazdzinski; Donna E Murray
Journal:  Biol Psychiatry       Date:  2015-04-09       Impact factor: 13.382

Review 6.  GABAergic contributions to alcohol responsivity during adolescence: insights from preclinical and clinical studies.

Authors:  Marisa M Silveri
Journal:  Pharmacol Ther       Date:  2014-03-11       Impact factor: 12.310

Review 7.  How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal.

Authors:  Ansel T Hillmer; Graeme F Mason; Lisa M Fucito; Stephanie S O'Malley; Kelly P Cosgrove
Journal:  Alcohol Clin Exp Res       Date:  2015-10-28       Impact factor: 3.455

8.  J-difference-edited MRS measures of γ-aminobutyric acid before and after acute caffeine administration.

Authors:  Georg Oeltzschner; Helge J Zöllner; Marc Jonuscheit; Rotem S Lanzman; Alfons Schnitzler; Hans-Jörg Wittsack
Journal:  Magn Reson Med       Date:  2018-05-12       Impact factor: 4.668

9.  Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment-naive individuals with alcohol use disorder.

Authors:  James J Prisciandaro; Joseph P Schacht; Andrew P Prescot; Helena M Brenner; Perry F Renshaw; Truman R Brown; Raymond F Anton
Journal:  Addict Biol       Date:  2019-08-01       Impact factor: 4.280

10.  Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition.

Authors:  Marisa M Silveri; Jennifer T Sneider; David J Crowley; Michael J Covell; Deepa Acharya; Isabelle M Rosso; J Eric Jensen
Journal:  Biol Psychiatry       Date:  2013-03-14       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.